Cleared Traditional

K142735 - The Optilite IgG3 kit

K142735 is the FDA 510(k) clearance for The Optilite IgG3 kit by The Binding Site Group , Ltd.. It is a Class 2 Immunology device (product code CFN) cleared through the Traditional 510(k) pathway after a 89-day FDA review.

K142735 · The Binding Site Group , Ltd. · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2014
Decision
89d
Days
Class 2
Risk

K142735 is an FDA 510(k) clearance for the The Optilite IgG3 kit. Classified as Method, Nephelometric, Immunoglobulins (g, A, M) (product code CFN), Class II - Special Controls.

Submitted by The Binding Site Group , Ltd. (Birmingham, GB). The FDA issued a Cleared decision on December 21, 2014 after a review of 89 days - a notably fast clearance cycle.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 866.5510 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all The Binding Site Group , Ltd. devices

Submission Details

510(k) Number K142735 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 23, 2014
Decision Date December 21, 2014
Days to Decision 89 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
15d faster than avg
Panel avg: 104d · This submission: 89d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFN Method, Nephelometric, Immunoglobulins (g, A, M)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.5510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - CFN Method, Nephelometric, Immunoglobulins (g, A, M)

All 51
Devices cleared under the same product code (CFN) and FDA review panel - the closest regulatory comparables to K142735.
Optilite IgA CSF Kit
K183151 · The Binding Site Group , Ltd. · Jan 2019
DxC 700 AU Clinical Chemistry Analyzer, AU IgG Reagent
K162208 · Beckman Coulter, Inc. · Jan 2017
Optilite IgG4 Kit
K150526 · The Binding Site Group , Ltd. · May 2015
BECKMAN COULTER IMMAGE IMMUNOCHEMISTRY SYSTEM LOW CONCENTRATION IMMUNOGLOBULIN, BECKMAN COULTER
K130122 · Beckman Coulter, Inc. · Jan 2014
HUMAN IGA CSF KIT FOR USE ON SPAPLUS
K120901 · The Binding Site Group , Ltd. · May 2013
HUMAN IGG CSF KIT
K120749 · The Binding Site Group , Ltd. · May 2013